Kenneth Abramowitz is listed as a director on 8 SEC Form D filings by 2 issuers between Feb 2010 and Mar 2019: OPTISCAN BIOMEDICAL CORP (Hayward, CA — other health care — 2016–2019; $31.5M reported sold to 16 investors) and EKOS CORP (Bothell, WA — industry reported as "Other" — 2010–2011; $5.5M reported sold to 24 investors).
What this means 2 separate companies raised money with this person listed as director, over about 9 years. Across those companies the filings report $37M sold in total.
Listed alongside Peter Rule (6 shared filings), Annette Campbell-White (5 shared filings), Melissa Daniels (5 shared filings), Richard Robb (5 shared filings), Robert Hubert (5 shared filings) and 10 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Kenneth. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 8 public filings for Kenneth Abramowitz and found 10 differences: Bankruptcy case: Paul Mieyal; No amendment in the last 12 months on an offering that may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.